Ketoconazole: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "6 mg" to "6mg") |
Neil.m.young (talk | contribs) (Text replacement - "0 mg" to "0mg") |
||
| Line 7: | Line 7: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===Fungal infections=== | ===Fungal infections=== | ||
*200- | *200-400mg PO qday | ||
===Prostate cancer=== | ===Prostate cancer=== | ||
* | *400mg PO q8h | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 03:36, 20 July 2016
Administration
- Type: Antifungal [1]
- Dosage Forms:
- Routes of Administration: PO, topical
- Common Trade Names:
Adult Dosing
Fungal infections
- 200-400mg PO qday
Prostate cancer
- 400mg PO q8h
Pediatric Dosing
Fungal infectionss (2 years and up)
- 3.3-6.6mg/kg PO qday
Special Populations
- Pregnancy Rating: C
- Lactation risk: Safety Unknown
Renal Dosing
- Adult: no adjustment
- Pediatric: no adjustment
Hepatic Dosing
- Adult: contraindicated in liver disease
- Pediatric: contraindicated in liver disease
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hepatotoxicity
- Adrenal insufficiency
- Hypersensitivity reaction
- Anaphylaxis
- Thrombocytopenia
- Leukopenia
- Hemolytic anemia
Common
Pharmacology
- Half-life: 8 h
- Metabolism: Liver (CYP450)
- Excretion: feces > urine
Mechanism of Action
- Inhibits synthesis of cell membrane ergosterol
Comments
See Also
References
- ↑ Epocrates, 2015.